Special Offer! - Free Pharmacy Design - Limited Time Offer, Hurry Up & Register Now

My Cart
In stock

BENDAMUSTINE-VENUS 100 mg Lyophilisate for solution for injection Vial

In stock
Only 1 left
SKU
10331014232

BENDAMUSTINE-VENUS 100 mg is a potent lyophilisate for solution for injection, utilized in the treatment of various hematological cancers like Chronic Lymphocytic Leukemia (CLL), Non-Hodgkin's Lymphoma (NHL), and Multiple Myeloma. As an alkylating agent, it works by disrupting cancer cell DNA to inhibit their growth. This prescription medication provides a critical therapeutic option, administered intravenously by healthcare professionals.

BENDAMUSTINE-VENUS 100 mg: A Powerful Solution for Cancer Treatment


BENDAMUSTINE-VENUS 100 mg Lyophilisate for solution for injection is a specialized medication designed for the treatment of certain types of cancer.
As an alkylating agent, Bendamustine works by interfering with the DNA of cancer cells, preventing their growth and division, which helps to slow down or stop the progression of the disease.
It is primarily indicated for patients with Chronic Lymphocytic Leukemia (CLL), Non-Hodgkin's Lymphoma (NHL), and Multiple Myeloma, providing a crucial therapeutic option in these challenging conditions.

Benefits of Use

  • Effective in treating specific hematological malignancies, including Chronic Lymphocytic Leukemia (CLL) and certain types of Non-Hodgkin's Lymphoma (NHL).
  • Offers a targeted approach to disrupt cancer cell proliferation, contributing to disease control and remission.
  • Used as a key component in various chemotherapy regimens, either as a monotherapy or in combination with other agents.

How to Use

  1. BENDAMUSTINE-VENUS 100 mg must be prepared and administered by a healthcare professional experienced in oncology.
  2. The lyophilisate should be reconstituted with a specified volume of sterile water for injection according to the manufacturer's instructions.
  3. The reconstituted solution is then further diluted with a compatible intravenous fluid (e.g., 0.9% sodium chloride or 5% dextrose) before administration.
  4. It is administered as an intravenous infusion over a period of 30 to 60 minutes, typically on specific days of a treatment cycle.
  5. Dosage and frequency depend on the patient's condition, weight, and the specific cancer being treated, as determined by the physician.

Caution & Warnings

  • Bone Marrow Suppression: May cause severe myelosuppression, leading to anemia, neutropenia, and thrombocytopenia. Regular blood count monitoring is essential.
  • Infections: Increased risk of serious infections, including opportunistic infections, due to immunosuppression.
  • Tumor Lysis Syndrome: May occur, especially in patients with high tumor burden. Adequate hydration and monitoring are crucial.
  • Hypersensitivity Reactions: Acute and severe hypersensitivity reactions, including anaphylaxis, can occur. Emergency equipment should be readily available.
  • Hepatotoxicity & Nephrotoxicity: Monitor liver and kidney function during treatment.
  • Pregnancy and Lactation: Harmful to a fetus; not recommended during pregnancy. Women of childbearing potential should use effective contraception. Avoid breastfeeding during treatment.
  • Extravasation: Avoid extravasation during infusion as it can cause local tissue damage.

Ingredients

Each vial contains:
  • Bendamustine hydrochloride equivalent to 100 mg Bendamustine.

Product Details

BENDAMUSTINE-VENUS 100 mg is presented as a sterile, white to off-white lyophilized powder in a glass vial.
It is designed for single-use and must be reconstituted and diluted prior to intravenous administration.
Store unopened vials in a refrigerator at 2C to 8C (36F to 46F) and protect from light.
Keep out of reach of children.
More Information
Gtin 2606257632
Recommended Sale Price 831.5
Is Wasfaty Product No
Brand Not Defined
Ingredient Name BENDAMUSTINE HYDROCHLORIDE
SFDA Reg. No 2606257632
IBC 2606257632
Drug Type Prescription
Scientific Name Bendamustine hydrochloride
Strength 100
Strength Unit mg
Form Lyophilisate for solution for injection
Admin Route Intravenous
Size 1
Size Unit Vial
Package Types Vial
Package Size 1 Vial
Storage conditions Store unopened vials in a refrigerator at 2C to 8C (36F to 46F) and protect from light.
Refrigerator Storage Yes